SM
GEVA

Sabby Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Sabby Management’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-285
Closed -$1.84M – 303
2013
Q4 		$1.84M Sell
285
-635
-69% -$37.7K 0.12% 88
2013
Q3 		$5.83M Buy
+920
New +$45.3K 0.38% 52

Sabby Management's GEVA Position: Q2 2015 in Review

Sabby Management sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 3,013 shares — an estimated $294K sold.

Sabby Management first reported a position in GEVA in Q1 2014 and held it in 3 quarters. The position peaked at $1.12M in Q1 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Sabby Management reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Sabby Management sold 3,013 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $294K.
  • Sabby Management first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q1 2014 and held it in 3 quarters.
  • Sabby Management's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $1.12M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Sabby Management's 13F filing for Q2 2015, filed 14 Aug 2015.